Abstract
Cheng S-L, Lin S-M, Peng C-K, et al. A real-world study to evaluate effectiveness of mepolizumab in treating severe asthma in Taiwan (REMIT). Therapeutic Advances in Respiratory Disease. 2025;19. doi:10.1177/17534666241308406
The name of the co-author, ‘Rafael Alfonso-Christancho’ was misspelt in the published version of the article. It has been corrected to ‘Rafael Alfonso-Cristancho’. This correction has no influence on the original experiments and maintains the scholarly validity and integrity of the article.
The article has been updated with the change.